Q: What are the Open Access Journals are available in your Publishing group?
Ans: Please visit the mentioned link [email protected] to view the list of Journals that are available with us.
Q: How can I submit my paper?
The candidate can submit Manuscript in email to [email protected] or submit from the Journal Web page
Q: What is the time required to publish my paper?
Ans: The peer process will take a minimum of 30 business days. After peer revise process, it will be published within 3 days after acceptance of the paper.
Q: How can I join as Reviewer to this Journal?
Ans: You can write your interest in email to [email protected] and we will get back to you in 3-4 days.
Q: Do Editor have to work continuously?
Ans: No, the editorial office will be helping you whenever required as we understand that you may be busy in other commitments.
Q: Whom do I have to contact at the Editorial office if I have any queries?
Ans: Kindly email your query to [email protected]. Editorial office or the respective Journal Managing Editor will respond you in 3-4 days.
Q: What is the eligibility if I would like to review a manuscript?
Ans: The reviewers are assigned by the Editors as per the research matching to the topic of manuscript. Self registered peer reviewers must be having a few published papers in the field of interest they mentioned.
Q: Do you charge for a manuscript submission?
Ans: There are no charges for manuscript submission. The authors only need to pay the article processing charges once the article is accepted.
Q: Is there any limit to review papers?
Ans: No. You may review as many manuscripts you wish according to manuscript topic match your interest.
Q: Why should an author pay the article processing charge?
In Open Access mode of publication, the scholarly literature will be made available to the researchers free of cost without any subscription charges. The whole maintenance of the operations i.e production of full text and PDF formats as well as archiving and indexing the published articles permanently through the article processing charges only. However, fee discounts will be provided to the authors from low income countries (According to World Bank classification).
Published : 17th September 2024
Authors : Ezegbe Chekwube Andrew1,4,*, Nwankwo Emmanuel Chinedu1, Okafor Nnedimma Pauline1, Adaka Uchechukwu Bill1, Odo Kenechi Benjamin1, Anikwe Celestine Chidera2, Ezegbe Amarachi Grace3, Onyishi Doris Chiagozie1, Anyaoha Cross-Raphael Chukwuebuka1, Ugorji Anita Chidera1, Ikechukwu Miracle Chiemelie1, Nwodo Adanne Judith1, Aniagwu Ifunanya Sheila1, Onunkwo Chukwunwike Godswill1
Citation : Andrew EC, et al. (2024). Preparation and In Vitro Evaluation of Ranitidine Floating Microspheres in The Treatment of Gastrointestinal Infections. Mathews J Pharma Sci. 8(2):36.
Published : 16th September 2024
Authors : Keme K Yenagoa1,*, Samuel J Bunu2, Mao E Bunu3
Citation : Yenagoa KK, et al. (2024). Correlates and Modalities of Tackling Substance Abuse Among Tertiary and Secondary School Students in Bayelsa State. Mathews J Pharma Sci. 8(2):33.
Published : 05th July 2024
Authors : Ezegbe Chekwube Andrew1,4,* Anikwe Celestine Chidera2, Uzondu Samuel WisdomofGod3,4, Okorie James Ekemezie1, Okafor Nnedimma Pauline1, Ezegbe Amarachi Grace5, Agu Kenechukwu Christian1, Okorafor Ezinne Chinemerem6, Aniagwu Ifunanya Sheila1
Citation : Andrew EC, et al. (2024). Formulation and in Vitro Evaluation of Liquisolid Compact of Celecoxib. Mathews J Pharma Sci. 8(2):31.
Published : 02nd July 2024
Authors : Vaibhav Adhao*, Jaya Ambhore, Anant Bhuskat, Dishali Talokar
Citation : Adhao V, et al. (2024). A Review on Analytical Methodologies for the Estimation of Anti-Retroviral Drugs Cabotegravir and Rilpivirine. Mathews J Pharma Sci. 8(1):30.
Published : 28th June 2024
Authors : Paolo Zanirato1,*, Silvia Businelli2
Citation : Zanirato P, et al. (2024). Synthesis and Antidiseas Evaluation of Some Bis-Heteroaryls (Thiophene or Selenophene) 1,2,3-triazoles C-trimethylsilylated. Mathews J Pharma Sci. 8(1):29.
Published : 13th June 2024
Authors : Amarachi Salome Chime1, Chekwube Andrew Ezegbe1,3,* Chidinma Judith Iyanyi1, Chukwunwike Godswill Onunkwo1, Amarachi Grace Ezegbe2, Nnedimma Pauline Okafor1
Citation : Chime AS, et al. (2024). Formulation, In-Vitro and In-Vivo Evaluation of Lamivudine-Loaded Solid Lipid Nanoparticles (SLNs). Mathews J Pharma Sci. 8(1):28.